Damian Labuda

Université de Montréal

Papers

1

Total Citations

76

H-Index

1

About

Damian Labuda is a leading figure in human population genetics and pharmacogenomics, whose work has profoundly shaped our understanding of genetic diversity and its implications for health. His research centers on the evolutionary history of human populations, particularly through the analysis of Y-chromosome and mitochondrial DNA variation, as well as the genetic basis of drug metabolism. Labuda is perhaps best known for pioneering high-throughput methods to detect clinically relevant genetic variants, exemplified by his 1999 paper on the rapid detection of CYP1A1, CYP2D6, and NAT variants using multiplex PCR and allele-specific oligonucleotide assays—a foundational contribution that has garnered 76 citations and enabled widespread pharmacogenetic screening. His major contributions include elucidating the peopling of the Americas and the genetic structure of Native American and Siberian populations, as well as identifying key mutations affecting drug response and disease susceptibility. With a career spanning decades, Labuda’s work has been cited thousands of times, reflecting its enduring impact on both evolutionary biology and personalized medicine. His achievements have earned him recognition as a pioneer in integrating population genetics with clinical applications, inspiring a generation of researchers to explore the interplay between human history and health.

Research Focus

Key Achievements

1
H-Index
1
Papers
76
Total Citations
76
Avg Citations/Paper
🏆 Most Cited Paper
Rapid Detection of CYP1A1, CYP2D6, and NAT Variants by Multiplex Polymerase Chain Reaction and Allele-Specific Oligonucleotide Assay
76 citations · 1999
📈 Most Prolific Year: 1999 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Université de Montréal

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago